CD39/adenosine pathway is involved in AIDS progression.
HIV-1 infection is characterized by a chronic activation of the immune system and suppressed function of T lymphocytes. Regulatory CD4+ CD25(high) FoxP3+CD127(low) T cells (Treg) play a key role in both conditions. Here, we show that HIV-1 positive patients have a significant increase of Treg-associ...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6978a6a1af86471db9fda97b11c647d1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:6978a6a1af86471db9fda97b11c647d1 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:6978a6a1af86471db9fda97b11c647d12021-11-18T06:03:14ZCD39/adenosine pathway is involved in AIDS progression.1553-73661553-737410.1371/journal.ppat.1002110https://doaj.org/article/6978a6a1af86471db9fda97b11c647d12011-07-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/21750674/pdf/?tool=EBIhttps://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374HIV-1 infection is characterized by a chronic activation of the immune system and suppressed function of T lymphocytes. Regulatory CD4+ CD25(high) FoxP3+CD127(low) T cells (Treg) play a key role in both conditions. Here, we show that HIV-1 positive patients have a significant increase of Treg-associated expression of CD39/ENTPD1, an ectoenzyme which in concert with CD73 generates adenosine. We show in vitro that the CD39/adenosine axis is involved in Treg suppression in HIV infection. Treg inhibitory effects are relieved by CD39 down modulation and are reproduced by an adenosine-agonist in accordance with a higher expression of the adenosine A2A receptor on patients' T cells. Notably, the expansion of the Treg CD39+ correlates with the level of immune activation and lower CD4+ counts in HIV-1 infected patients. Finally, in a genetic association study performed in three different cohorts, we identified a CD39 gene polymorphism that was associated with down-modulated CD39 expression and a slower progression to AIDS.Maria NikolovaMatthieu CarriereMohammad-Ali JenabianSophie LimouMehwish YounasAyrin KökSophie HuëNabila SeddikiAnne HulinOlivier DelaneauHanneke SchuitemakerJoshua T HerbeckJames I MullinsMaria MuhtarovaArmand BensussanJean-François ZaguryJean-Daniel LelievreYves LévyPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 7, Iss 7, p e1002110 (2011) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Maria Nikolova Matthieu Carriere Mohammad-Ali Jenabian Sophie Limou Mehwish Younas Ayrin Kök Sophie Huë Nabila Seddiki Anne Hulin Olivier Delaneau Hanneke Schuitemaker Joshua T Herbeck James I Mullins Maria Muhtarova Armand Bensussan Jean-François Zagury Jean-Daniel Lelievre Yves Lévy CD39/adenosine pathway is involved in AIDS progression. |
description |
HIV-1 infection is characterized by a chronic activation of the immune system and suppressed function of T lymphocytes. Regulatory CD4+ CD25(high) FoxP3+CD127(low) T cells (Treg) play a key role in both conditions. Here, we show that HIV-1 positive patients have a significant increase of Treg-associated expression of CD39/ENTPD1, an ectoenzyme which in concert with CD73 generates adenosine. We show in vitro that the CD39/adenosine axis is involved in Treg suppression in HIV infection. Treg inhibitory effects are relieved by CD39 down modulation and are reproduced by an adenosine-agonist in accordance with a higher expression of the adenosine A2A receptor on patients' T cells. Notably, the expansion of the Treg CD39+ correlates with the level of immune activation and lower CD4+ counts in HIV-1 infected patients. Finally, in a genetic association study performed in three different cohorts, we identified a CD39 gene polymorphism that was associated with down-modulated CD39 expression and a slower progression to AIDS. |
format |
article |
author |
Maria Nikolova Matthieu Carriere Mohammad-Ali Jenabian Sophie Limou Mehwish Younas Ayrin Kök Sophie Huë Nabila Seddiki Anne Hulin Olivier Delaneau Hanneke Schuitemaker Joshua T Herbeck James I Mullins Maria Muhtarova Armand Bensussan Jean-François Zagury Jean-Daniel Lelievre Yves Lévy |
author_facet |
Maria Nikolova Matthieu Carriere Mohammad-Ali Jenabian Sophie Limou Mehwish Younas Ayrin Kök Sophie Huë Nabila Seddiki Anne Hulin Olivier Delaneau Hanneke Schuitemaker Joshua T Herbeck James I Mullins Maria Muhtarova Armand Bensussan Jean-François Zagury Jean-Daniel Lelievre Yves Lévy |
author_sort |
Maria Nikolova |
title |
CD39/adenosine pathway is involved in AIDS progression. |
title_short |
CD39/adenosine pathway is involved in AIDS progression. |
title_full |
CD39/adenosine pathway is involved in AIDS progression. |
title_fullStr |
CD39/adenosine pathway is involved in AIDS progression. |
title_full_unstemmed |
CD39/adenosine pathway is involved in AIDS progression. |
title_sort |
cd39/adenosine pathway is involved in aids progression. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2011 |
url |
https://doaj.org/article/6978a6a1af86471db9fda97b11c647d1 |
work_keys_str_mv |
AT marianikolova cd39adenosinepathwayisinvolvedinaidsprogression AT matthieucarriere cd39adenosinepathwayisinvolvedinaidsprogression AT mohammadalijenabian cd39adenosinepathwayisinvolvedinaidsprogression AT sophielimou cd39adenosinepathwayisinvolvedinaidsprogression AT mehwishyounas cd39adenosinepathwayisinvolvedinaidsprogression AT ayrinkok cd39adenosinepathwayisinvolvedinaidsprogression AT sophiehue cd39adenosinepathwayisinvolvedinaidsprogression AT nabilaseddiki cd39adenosinepathwayisinvolvedinaidsprogression AT annehulin cd39adenosinepathwayisinvolvedinaidsprogression AT olivierdelaneau cd39adenosinepathwayisinvolvedinaidsprogression AT hannekeschuitemaker cd39adenosinepathwayisinvolvedinaidsprogression AT joshuatherbeck cd39adenosinepathwayisinvolvedinaidsprogression AT jamesimullins cd39adenosinepathwayisinvolvedinaidsprogression AT mariamuhtarova cd39adenosinepathwayisinvolvedinaidsprogression AT armandbensussan cd39adenosinepathwayisinvolvedinaidsprogression AT jeanfrancoiszagury cd39adenosinepathwayisinvolvedinaidsprogression AT jeandaniellelievre cd39adenosinepathwayisinvolvedinaidsprogression AT yveslevy cd39adenosinepathwayisinvolvedinaidsprogression |
_version_ |
1718424670919720960 |